Nuvo Pharmaceuticals Inc NRIFF

One possible reason we have no partner yet

[longondmx]

I guess it would make sense that we would not have a partnership announcement until final approval. Afterall, labelling issues, such as for what (knee or all parts of body) and how often to use the product (ie. maximum 3 months, or unlimited) would significantly affect the potential of the product and consequently, the royalties/price a partner would have to pay for the rights to market it. For example, if the FDA's condition was for the product's label to indicate that treatment was for the Knee only for a maximum of 3 months (similar to Canada) the product would be less attractive than if the labelling had other parts of the body listed (ie. all joints, fingers toes, etc.) and no usage limitation. This could be one explanation why Dan has said that he is confident of full approval, as he knows that if he accepts FDA conditions as presented (3 month/knee only labelling), he could have the full approval with no additional issues. Rather than tell the public this, he may have decided to wait in order to ask FDA what it would take to have the product approved for joints, etc... I think we will hear about the issues within the next two weeks - if not this week.